# Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

> **NCT00547235** · — · NO_LONGER_AVAILABLE · sponsor: **Fred Hutchinson Cancer Center**

## Conditions studied

- Infection
- Precancerous/Nonmalignant Condition

## Interventions

- **BIOLOGICAL:** therapeutic allogeneic lymphocytes
- **PROCEDURE:** allogeneic bone marrow transplantation
- **RADIATION:** total-body irradiation

## Key facts

- **NCT ID:** NCT00547235
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** 2007-09
- **Primary completion:** 2012-12
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2010-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00547235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00547235, "Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00547235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*